Mixed Antagonist of Serotonin for Claudication Optimal Therapy
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
To investigate in patients suffering from intermittent claudication due to Fontaine stage II
PAD whether a 24-week treatment by SL650472 OD on top of clopidogrel may result in an
improvement of walking capacity, by comparing three doses of SL650472 to placebo, and to
calibrate such effect versus cilostazol